The Partnership for Safe Medicines (PSM) applauds the Food and Drug Administration (FDA) and the National Telecommunications and Information Administration (NTIA) pilot program established this week to curb unapproved opioids illegally available online by potentially suspending or blocking offending domain names.

[...]

The following policy resolution was passed unanimously at the May 8, 2020 Advisory Board meeting: The Partnership for Safe Medicines believes that counterfeit medical devices are dangerous to American patients and that the U.S. Food and Drug Administration (FDA) should have the unequivocal power to seize and destroy these dangerous products whether they are found…

[...]

The following policy resolution was passed unanimously at the Jan. 8, 2020 board meeting in Washington DC. The governing board of the Partnership for Safe Medicines votes today to reiterate that the Partnership is organized to focus entirely of the safety of medicine as it travels through the supply chain, as we have since our…

[...]

The Partnership for Safe Medicines (PSM) stands with our law enforcement partners in commending the U.S. Senate and the U.S. House of Representatives for their swift passage of S.3201, which would extend the DEA’s temporary scheduling of fentanyl-related substances to be Schedule I controlled substances for an additional 15 months. Without this reauthorization, criminals could…

[...]

Partnership for Safe Medicines Statement on Proposed Regulations to Import Prescription Medicines from Canada Washington, D.C. (December 18, 2019) – Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to today’s announcement by the Trump Administration and the proposed regulations to allow importation of prescription medicines: “Citizens of…

[...]

In case you missed it, Bloomberg’s Ben Elgin has published an “in-depth” piece on the connection between PhRMA and the Partnership for Safe Medicines. However, this has been public and widely reported on for years. More concerningly, the story misses the broader point about the clear safety concerns of foreign drug importation. Over the past…

[...]

WASHINGTON (August 26, 2019) – Shabbir Imber Safdar, Executive Director of The Partnership for Safe Medicines, released the following statement in response to Florida’s submission of a drug importation concept to the U.S. Department of Health and Human Services (HHS): “Florida’s Canadian Prescription Drug Importation Concept Paper [PDF] recently submitted to HHS demonstrates that Florida…

[...]

Partnership for Safe Medicines Statement on Reckless and Politically-Motivated Drug Importation Proposal Washington, D.C. (July 31, 2019) – Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to today’s announcement by HHS Secretary Alex Azar and FDA Commissioner Ned Sharpless: “Less than a year and a half ago,…

[...]

Washington, D.C. (June 11, 2019) – Shabbir Imber Safdar, executive director of the Partnership for Safe Medicines, released the following statement today in response to the signing of Florida’s drug importation bill: “Today, Florida’s governor put politics over the safety of residents across the state. Although this was widely expected, we remain committed to protecting…

[...]